Infliximab (REMICADE®) is an anti-inflammatory, monoclonal antibody for the treatment of Crohn's disease and rheumatoid arthritis, which is licensed from Centocor.
-
Schering Plough's biotechnology facility in Tuas, Singapore. -
Peginterferon alfa-2b (PEG-INTRON®) for the treatment of hepatitis C, which... -
Infliximab (REMICADE®) is an anti-inflammatory, monoclonal antibody for the...
Twitter
Facebook